DVAX
DYNAVAX TECHNOLOGIES CORP
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$15.50
+0.00%Latest reported
- Last report date
- Feb 19, 2026
- EPS actual
- $0.05
- EPS estimate
- $0.08
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 9
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +7.3%
- Revenue beats (12Q)
- 9
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Feb 19, 2026 | $0.08 | $0.05 | Miss -37.50% | — |
| Nov 5, 2025 | $0.14 | $0.21 | Beat 50.00% | $94.9M |
| Aug 7, 2025 | $0.12 | $0.14 | Beat 16.67% | $95.4M |
| Feb 20, 2025 | $0.05 | $0.05 | In line | $72.0M |
| Nov 7, 2024 | $0.11 | $0.12 | Beat 9.09% | $80.6M |
| Feb 22, 2024 | $0.00 | $0.00 | Beat 100.00% | $55.6M |
| Nov 2, 2023 | $0.01 | $0.10 | Beat 766.55% | $69.5M |
| Aug 3, 2023 | -$0.09 | $0.03 | Beat 133.33% | $60.2M |
| May 2, 2023 | -$0.12 | -$0.19 | Miss -58.33% | $46.9M |
| Feb 23, 2023 | $0.43 | $0.45 | Beat 4.65% | $184.5M |
| Nov 3, 2022 | $0.33 | $0.43 | Beat 30.30% | $167.7M |
| Aug 4, 2022 | $0.22 | $0.87 | Beat 295.45% | $256.5M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of May 4, 2026